InterShunt
InterShunt is dedicated to developing innovative solutions for heart failure patients, including the proprietary transcatheter system, PAS-C, which relieves elevated left atrial pressure by creating a left-to-right atrial shunt without requiring an implant or energy. The company's mission is to improve breathing and quality of life for the over 6 million Americans suffering from heart failure.
Industries
Nr. of Employees
small (1-50)
Products
Percutaneous atrial shunt catheter system
A catheter-delivered system designed to excise interatrial septal tissue and create a left-to-right atrial shunt to relieve elevated left atrial pressure in heart failure patients; described as not requiring an implant or energy delivery.
Percutaneous atrial shunt catheter system
A catheter-delivered system designed to excise interatrial septal tissue and create a left-to-right atrial shunt to relieve elevated left atrial pressure in heart failure patients; described as not requiring an implant or energy delivery.
Services
Transcatheter cardiac device R&D and clinical program development
Internal development of catheter-delivered cardiac devices and associated clinical program planning and oversight.
Transcatheter cardiac device R&D and clinical program development
Internal development of catheter-delivered cardiac devices and associated clinical program planning and oversight.
Expertise Areas
- Transcatheter device development
- Interventional cardiology procedures
- Heart failure device therapy
- Clinical development and trial management for medical devices
Key Technologies
- Transcatheter catheter systems
- Percutaneous catheter-based tissue excision
- Mechanical shunt-creation techniques
- Minimally invasive cardiac device design